Πέμπτη 14 Νοεμβρίου 2019


Risk factors for wheezing in primary health care settings in the tropics
The "International Study of Wheezing in Infants (EISL)", is a cross-sectional, population-based study, based on ISAAC. "(Http // www.isaac.auckland.ac.nz). It uses a validated questionnaire on early wheezing and risk/protective factors.
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
Efficacy and Safety of Twice-daily and Once-daily Olopatadine-Mometasone Combination Nasal Spray for Seasonal Allergic Rhinitis
GSP301 is an investigational fixed-dose combination nasal spray of olopatadine hydrochloride (antihistamine) and mometasone furoate (corticosteroid).
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
Adverse effects of TNF inhibitor in a patient with DiGeorge syndrome and juvenile idiopathic arthritis
DiGeorge syndrome (DGS) is the most common congenital chromosome deletion syndrome which appears in 1:4000 live births as the result of 22q11.2 microdeletion1. It is a primary immunodeficiency disease (PID), characterized with decreased T-cell numbers1,2. There is a growing body of evidence that DGS is associated with humoral immune deficiency (ID) as the result of B-lymphocyte functional deficit, leading to hypogammaglobulinemia1,2. Patients with DGS show increased incidence of infection and autoimmune...
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
GINA Updated 2019: Landmark Changes Recommended for Asthma Management
GINA, Global Initiative for Asthma, was launched in 1993 in collaboration with the National Heart, Lung, and Blood Institute, National Institutes of Health, and the World Health Organization. to improve the prevention and management of asthma worldwide. Their science committee updates asthma guidelines yearly and the 20191 report’s goals were to reduce the risk of serious asthma-related exacerbations: to avoid patient reliance on quick-relief medication: and to update asthma treatment goals. In the...
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
So, you’ve prescribed a biologic. Now what?
This is an exciting time in the field of allergy and immunology. The advent of biologic medications has undoubtedly revolutionized the landscape of asthma management. Many patients previously condemned to frequent hospitalizations, emergency department visits, and prednisone bursts can now live with minimal symptomatology. However, the fact that these biologics remain in their infancy poses several questions beyond eligibility criteria, choice of biologic, and dosing. Questions regarding duration...
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
The Stock Epinephrine Law - 5 Years Later and Counting
The School Access to Emergency Epinephrine Act was signed into law by President Obama on November 13, 2013 with bipartisan support (Public Law 113-48). The law amended the Public Health Service Act to increase the preference given to certain asthma-related grants in states that allow trained school personnel to administer epinephrine and maintain a stock epinephrine supply to treat suspected anaphylaxis. To qualify, states are also required to provide civil liability protection to trained staff acting...
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
Association of obstructive sleep apnea with severity of patients hospitalized for acute asthma
Studies suggest that obstructive sleep apnea (OSA) is associated with suboptimal disease control and worse chronic severity of asthma. However, little is known about the relations of OSA with acute asthma severity in hospitalized patients.
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
A twelve steps desensitization protocol for pediatric patients with hypersensitivity to PEG-asparaginase
Asparaginase is a chemotherapeutic used to treat hematological malignancies. Hypersensitivity reactions to native asparaginase (L-asparaginase) are described in up to 60% of patients1, in which case switching to alternative forms of asparaginase is recommended: pegylated-asparaginase (PEG-asparaginase), a readily available formulation, or Erwinia-asparaginase2; which is currently scarce. Although PEG-asparaginase is considered hypoallergenic, up to 25% of patients receiving it have allergic reactions3.
Annals of Allergy, Asthma & Immunology
Thu Nov 14, 2019 02:00
Trends in egg specific immunoglobulin levels during natural tolerance and oral immunotherapy
Allergy
Thu Nov 14, 2019 11:47
Validation of anti-Mi2 autoantibody testing by line blot
Publication date: Available online 14 November 2019Source: Autoimmunity ReviewsAuthor(s): Iago Pinal-Fernandez, Katherine Pak, Maria Casal-Dominguez, Yuji Hosono, Christopher Mecoli, Lisa Christopher-Stine, Andrew L. Mammen
Autoimmunity Reviews
Thu Nov 14, 2019 12:39
The Giants (biologicals) against the Pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritis
Publication date: Available online 14 November 2019Source: Autoimmunity ReviewsAuthor(s): Ennio Giulio Favalli, Marco Matucci-Cerinic, Zoltan SzekaneczAbstractRheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that, if untreated, can lead to disability and reduce the life expectancy of affected patients. Over the last two decades the improvement of knowledge of the pathogenetic mechanisms leading to the development of the disease has profoundly changed the treatment strategies...
Autoimmunity Reviews
Thu Nov 14, 2019 12:39
Comparative United States autoimmune disease rates for 2010–2016 by sex, geographic region, and race
Publication date: Available online 14 November 2019Source: Autoimmunity ReviewsAuthor(s): Melissa H. Roberts, Esther ErdeiAbstractPurpose: AIDs may disproportionately impact specific racial groups, but autoimmune (AID) prevalence information by minority racial group is sparse for many AIDs. The objective of this analysis was to supplement previously published AID prevalence rates by providing information on race rate ratios (minority race populations compared to Caucasian populations) in the United...
Autoimmunity Reviews
Thu Nov 14, 2019 12:39
Aetiology and pathogenesis of paraneoplastic autoimmune disorders
Publication date: Available online 13 November 2019Source: Autoimmunity ReviewsAuthor(s): Guojun Geng, Xiuyi Yu, Jie Jiang, Xinhua YuAbstractParaneoplastic autoimmune disorders (PAD) represent a group of autoimmune diseases associated with neoplasms. As a consequence of a remote autoimmunity-mediated effect, PAD are found in multiple organs or tissues, including the skin, blood and nervous system. Compared with non-paraneoplastic autoimmune diseases, PAD have different aetiologies, pathologies, disease...
Autoimmunity Reviews
Thu Nov 14, 2019 12:39

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου